Type 1 and type 2 diabetes require different approaches. Discover the 9 essential distinctions that affect daily management ...

The Oklahoma House passed Bill 1380 to reduce insulin costs, now heading to the Senate. The bill aims to make insulin ...

With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...

New research suggests that antibiotics given to infants during a critical developmental window may increase their risk of ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Oppenheimer lowered the firm’s price target on Biomea Fusion (BMEA) to $10 from $50 and keeps an Outperform rating on the shares after the ...

Also known as type 1.5 diabetes, here’s what to know about the onset, symptoms, diagnosis, and treatment options for latent ...

Global CEO of Eli Lilly, world’s pioneer Insulin manufacturers, David Ricks called on Union Minister of State (Independent ...

Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the Advanced Technologies ...

Dr. Jitendra Singh, a renowned endocrinologist himself, emphasized the unique metabolic challenges faced by India due to its ...